This Week Health
Alex's Lemonade Stand This Week Health
March 7, 2024

Dexcom's first-ever over-the-counter glucose monitor patch gets FDA clearance

CNBC
|
Summary
Dexcom has received FDA clearance for its first over-the-counter continuous glucose monitor, Stelo, targeting patients with Type 2 diabetes who do not use insulin. This marks the first time a glucose biosensor will be available without a prescription, with sales starting in the summer of 2024. Stelo aims to improve diabetes management by tracking glucose levels in real-time, sending data wirelessly to a smartphone for more effective monitoring of the user's condition.

Explore Related Content

No mapped captivate categories found for this news story.

Get Daily Headlines Straight to Your Inbox.

Subscribe Now
Healthcare Transformation Powered by Community

© Copyright 2024 Health Lyrics All rights reserved